Physician profile
James Mills
NPI 1609073246
$290,383.24
in general payments reported to CMS, 2019-2025
12 companies · $51K in 2025
The $51K reported for 2025 was more than what 95% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38K · 2020: $36K · 2021: $42K · 2022: $42K · 2023: $45K · 2024: $36K · 2025: $51K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $128K · Food and Beverage: $2,517 · Travel and Lodging: $2,197.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $127,785.16 |
| Food and Beverage | $2,517.39 |
| Travel and Lodging | $2,196.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $282,374.14 | 2019-2025 | Coalition Agx / Agx Rp, Coalition Agx, Excelsiusgps Robotic Navigation System |
| Stryker Corporation | $2,829.94 | 2019-2022 | |
| Medtronic, INC. | $2,502.76 | 2021-2025 | Stealthstation S8 Platform, Mazor X System, O-Arm |
| Abbott Laboratories | $2,285.90 | 2019-2025 | Proclaim, Penta, Octrode |
| Sanara Medtech INC. | $189.83 | 2022 | |
| Medtronic USA, INC. | $70.73 | 2019-2020 | |
| Novocure INC. | $36.72 | 2019 | |
| Integra Lifesciences Corporation | $23.10 | 2024 | Instruments-Orthopedic, Microfrance, Integra Duo |
| Aesculap, INC. | $20.02 | 2024 | Aesculap |
| Cerapedics INC. | $18.73 | 2021 | |
| Zimvie INC. | $17.17 | 2024 | |
| Providence Medical Technology, INC. | $14.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Mills listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.